Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Quotient Clinical at AAPS 2013

Published: Friday, November 08, 2013
Last Updated: Friday, November 08, 2013
Bookmark and Share
AAPS annual meeting and exposition to be held in San Antonio, Texas, from the 10th to the 14th of November.

Quotient Clinical will be showcasing the benefits of its unique, integrated approach to formulation development, real-time manufacturing and clinical testing on booth 2800 at this year’s American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition.

Held in San Antonio, Texas, from the 10th to the 14th of November, this meeting will provide delegates with the opportunity to see some of the latest developments in the pharmaceutical sector, including a variety of projects which have benefitted from the reduced costs and faster time-to-market offered by Quotient Clinical’s innovative development platform.

Quotient Clinical will be supporting several other activities and events at the meeting, including a RapidFACT™ user group meeting and six poster presentations.

The RapidFACT user meeting will aim to build on last year’s highly successful event, and will include a number of customer presentations, as well as an open forum to discuss various aspects of the RapidFACT process.

On the final day of the conference, Dr Alyson Connor, Director of Exploratory Clinical Pharmacology at Quotient Clinical, will be participating in a symposium featuring a number of prominent speakers from academia and industry entitled Understanding in vivo dissolution: can imaging tools provide the missing link?

Alyson will be discussing the practicalities of tracking oral dosage form performance using scintigraphic imaging, and participating in a panel discussion on the use of imaging tools in pharmaceutical research.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Quotient Clinical Expands Data Sciences Capability
The expansion comes in response to growing customer demand for the Data Sciences service.
Wednesday, September 28, 2016
Quotient Prepares for the Japenese Market
Announcement confirms the completion of Quotients first clinical program involving Japanese healthy volunteers.
Wednesday, March 16, 2016
Quotient Clinical Celebrates its 100th RapidFACT® Program
Quotient Clinical, the Translational Pharmaceutics® company, has announced that it has completed its 100th RapidFACT (Rapid Formulation development And Clinical Testing) program – a significant milestone in the growth of this service, which addresses drug R&D productivity issues.
Wednesday, February 10, 2016
Quotient Clinical Acquires Co-Formulate
Quotient Clinical, the Translational Pharmaceutics® company, has announced that it has acquired formulation development specialist Co-Formulate Limited.
Thursday, December 17, 2015
Quotient Clinical Acquired by GHO Capital
Quotient Clinical, the Translational Pharmaceutics® company, has announced that it has been acquired by specialist healthcare investor GHO Capital, with financial details of the transaction remaining undisclosed.
Thursday, December 03, 2015
Quotient Clinical Begins Prostate Cancer Project for Druggability Technologies
The program will assess new formulations using DRGT’s proprietary Super-API technology, and aims to reduce dose and address food effects associated with the drug.
Wednesday, June 24, 2015
Quotient Clinical Completes Innovative First-In-Human Program
First-in-human clinical program designed to develop an optimal oral formulation.
Thursday, April 23, 2015
Quotient Clinical Announces ADME Success in Oncology
Company to supply 14C radiolabelled drug products to specialist oncology clinics globally.
Thursday, April 02, 2015
Quotient Clinical Showcases ‘Gold Standard’ Human ADME Studies and Applications
Company will present a symposium and three poster publications at ISSX/JSSX 2014.
Wednesday, September 24, 2014
Quotient Clinical Celebrates its 50th RapidFACT™ Program
The 50th Rapid Formulation development And Clinical Testing program marks a significant milestone in the development of this service.
Thursday, February 06, 2014
Quotient Clinical Announces New Investment In Translational Pharmaceutics™
The investment represents a significant expansion of Quotient's capacity and capabilities.
Tuesday, November 19, 2013
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Researchers Find a Gap in the Brain’s Firewall Against Parkinson’s Disease
Researchers at NIH have found mouse study that identified a key player in the progression of the disorder.
Fat Cells That Amplify Nerve Signals in Response to Cold Also Affect Blood Sugar Metabolism
Researchers at UTSW have found that the protein connexin 43 forms cell-to-cell communication channels on the surface of emerging beige fat cells that amplify the signals from those few nerve fibers.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Faecal Bacteria Linked to Body Fat
Researchers at King’s College London have found a new link between the diversity of bacteria in human poo – known as the human faecal microbiome - and levels of abdominal body fat.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!